Shares of HealthStream, Inc. (NASDAQ:HSTM – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the five research firms that are covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation, two have issued a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $31.50.
Several analysts recently issued reports on the company. JMP Securities reissued a “market perform” rating on shares of HealthStream in a research note on Thursday, February 6th. Canaccord Genuity Group raised their price target on HealthStream from $28.00 to $29.00 and gave the company a “hold” rating in a report on Wednesday, October 23rd. Barclays lifted their target price on HealthStream from $32.00 to $34.00 and gave the stock an “overweight” rating in a report on Wednesday, October 23rd. Finally, Craig Hallum raised shares of HealthStream to a “strong-buy” rating in a research report on Thursday, October 17th.
Get Our Latest Stock Report on HealthStream
HealthStream Trading Up 1.0 %
Hedge Funds Weigh In On HealthStream
Several institutional investors and hedge funds have recently bought and sold shares of the company. State Street Corp increased its stake in shares of HealthStream by 1.2% in the 3rd quarter. State Street Corp now owns 974,235 shares of the technology company’s stock valued at $28,097,000 after purchasing an additional 11,976 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of HealthStream by 2.9% in the 3rd quarter. Geode Capital Management LLC now owns 674,764 shares of the technology company’s stock valued at $19,463,000 after purchasing an additional 18,779 shares during the last quarter. Harbor Capital Advisors Inc. increased its position in shares of HealthStream by 3.7% during the fourth quarter. Harbor Capital Advisors Inc. now owns 414,787 shares of the technology company’s stock valued at $13,190,000 after acquiring an additional 14,754 shares during the last quarter. Copeland Capital Management LLC grew its stake in shares of HealthStream by 17,363.4% in the fourth quarter. Copeland Capital Management LLC now owns 379,306 shares of the technology company’s stock valued at $12,062,000 after buying an additional 377,134 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its stake in HealthStream by 2.2% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 223,262 shares of the technology company’s stock worth $7,100,000 after purchasing an additional 4,815 shares during the period. 69.58% of the stock is owned by hedge funds and other institutional investors.
About HealthStream
HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.
Recommended Stories
- Five stocks we like better than HealthStream
- Retail Stocks Investing, Explained
- Merck: 4 No-Brainer Reasons to Buy This Dip
- What is the Dogs of the Dow Strategy? Overview and Examples
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- Stock Dividend Cuts Happen Are You Ready?
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.